These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 11150513

  • 1. Leukemia inhibitory factor enhances mast cell growth in a mast cell/fibroblast co-culture system through stat3 signaling pathway of fibroblasts.
    Hiragun T, Morita E, Mihara S, Tanaka T, Gyotoku E, Kameyoshi Y, Yamamoto S.
    FEBS Lett; 2000 Dec 29; 487(2):219-23. PubMed ID: 11150513
    [Abstract] [Full Text] [Related]

  • 2. The IL-6 family cytokines, interleukin-6, interleukin-11, oncostatin M, and leukemia inhibitory factor, enhance mast cell growth through fibroblast-dependent pathway in mice.
    Gyotoku E, Morita E, Kameyoshi Y, Hiragun T, Yamamoto S, Hide M.
    Arch Dermatol Res; 2001 Nov 29; 293(10):508-14. PubMed ID: 11820727
    [Abstract] [Full Text] [Related]

  • 3. Contributions of leukemia inhibitory factor receptor and oncostatin M receptor to signal transduction in heterodimeric complexes with glycoprotein 130.
    Hermanns HM, Radtke S, Haan C, Schmitz-Van de Leur H, Tavernier J, Heinrich PC, Behrmann I.
    J Immunol; 1999 Dec 15; 163(12):6651-8. PubMed ID: 10586060
    [Abstract] [Full Text] [Related]

  • 4. Leptin receptor (OB-R) oligomerizes with itself but not with its closely related cytokine signal transducer gp130.
    Nakashima K, Narazaki M, Taga T.
    FEBS Lett; 1997 Feb 10; 403(1):79-82. PubMed ID: 9038364
    [Abstract] [Full Text] [Related]

  • 5. Formation of autocrine loops in human cerebral meningioma tissue by leukemia inhibitor factor, interleukin-6, and oncostatin M: inhibition of meningioma cell growth in vitro by recombinant oncostatin M.
    Schrell UM, Koch HU, Marschalek R, Schrauzer T, Anders M, Adams E, Fahlbusch R.
    J Neurosurg; 1998 Mar 10; 88(3):541-8. PubMed ID: 9488310
    [Abstract] [Full Text] [Related]

  • 6. A selective switch-on system for self-renewal of embryonic stem cells using chimeric cytokine receptors.
    Nakamura T, Arai T, Takagi M, Sawada T, Matsuda T, Yokota T, Heike T.
    Biochem Biophys Res Commun; 1998 Jul 09; 248(1):22-7. PubMed ID: 9675079
    [Abstract] [Full Text] [Related]

  • 7. Activation of gp130 transduces hypertrophic signals via STAT3 in cardiac myocytes.
    Kunisada K, Tone E, Fujio Y, Matsui H, Yamauchi-Takihara K, Kishimoto T.
    Circulation; 1998 Jul 28; 98(4):346-52. PubMed ID: 9711940
    [Abstract] [Full Text] [Related]

  • 8. STAT3 activation is a critical step in gp130-mediated terminal differentiation and growth arrest of a myeloid cell line.
    Minami M, Inoue M, Wei S, Takeda K, Matsumoto M, Kishimoto T, Akira S.
    Proc Natl Acad Sci U S A; 1996 Apr 30; 93(9):3963-6. PubMed ID: 8632998
    [Abstract] [Full Text] [Related]

  • 9. Activation of JAK-STAT and MAP kinases by leukemia inhibitory factor through gp130 in cardiac myocytes.
    Kunisada K, Hirota H, Fujio Y, Matsui H, Tani Y, Yamauchi-Takihara K, Kishimoto T.
    Circulation; 1996 Nov 15; 94(10):2626-32. PubMed ID: 8921810
    [Abstract] [Full Text] [Related]

  • 10. The carboxyl-terminal domains of gp130-related cytokine receptors are necessary for suppressing embryonic stem cell differentiation. Involvement of STAT3.
    Ernst M, Novak U, Nicholson SE, Layton JE, Dunn AR.
    J Biol Chem; 1999 Apr 02; 274(14):9729-37. PubMed ID: 10092661
    [Abstract] [Full Text] [Related]

  • 11. Paracrine induction of stem cell renewal by LIF-deficient cells: a new ES cell regulatory pathway.
    Dani C, Chambers I, Johnstone S, Robertson M, Ebrahimi B, Saito M, Taga T, Li M, Burdon T, Nichols J, Smith A.
    Dev Biol; 1998 Nov 01; 203(1):149-62. PubMed ID: 9806780
    [Abstract] [Full Text] [Related]

  • 12. Differential inhibition of IL-6-type cytokine-induced STAT activation by PMA.
    Terstegen L, Maassen BG, Radtke S, Behrmann I, Schaper F, Heinrich PC, Graeve L, Gatsios P.
    FEBS Lett; 2000 Jul 28; 478(1-2):100-4. PubMed ID: 10922477
    [Abstract] [Full Text] [Related]

  • 13. Receptor subunit-specific action of oncostatin M in hepatic cells and its modulation by leukemia inhibitory factor.
    Wang Y, Robledo O, Kinzie E, Blanchard F, Richards C, Miyajima A, Baumann H.
    J Biol Chem; 2000 Aug 18; 275(33):25273-85. PubMed ID: 10854424
    [Abstract] [Full Text] [Related]

  • 14. Pituitary corticotroph SOCS-3: novel intracellular regulation of leukemia-inhibitory factor-mediated proopiomelanocortin gene expression and adrenocorticotropin secretion.
    Auernhammer CJ, Chesnokova V, Bousquet C, Melmed S.
    Mol Endocrinol; 1998 Jul 18; 12(7):954-61. PubMed ID: 9658400
    [Abstract] [Full Text] [Related]

  • 15. Activation of cytokine signaling through leukemia inhibitory factor receptor (LIFR)/gp130 attenuates ischemic brain injury in rats.
    Suzuki S, Yamashita T, Tanaka K, Hattori H, Sawamoto K, Okano H, Suzuki N.
    J Cereb Blood Flow Metab; 2005 Jun 18; 25(6):685-93. PubMed ID: 15716858
    [Abstract] [Full Text] [Related]

  • 16. LIF/STAT3 signaling fails to maintain self-renewal of human embryonic stem cells.
    Dahéron L, Opitz SL, Zaehres H, Lensch MW, Andrews PW, Itskovitz-Eldor J, Daley GQ.
    Stem Cells; 2004 Jun 18; 22(5):770-8. PubMed ID: 15342941
    [Abstract] [Full Text] [Related]

  • 17. A sweat gland-derived differentiation activity acts through known cytokine signaling pathways.
    Habecker BA, Symes AJ, Stahl N, Francis NJ, Economides A, Fink JS, Yancopoulos GD, Landis SC.
    J Biol Chem; 1997 Nov 28; 272(48):30421-8. PubMed ID: 9374533
    [Abstract] [Full Text] [Related]

  • 18. Different epitopes are required for gp130 activation by interleukin-6, oncostatin M and leukemia inhibitory factor.
    Timmermann A, Pflanz S, Grötzinger J, Küster A, Kurth I, Pitard V, Heinrich PC, Müller-Newen G.
    FEBS Lett; 2000 Feb 25; 468(2-3):120-4. PubMed ID: 10692570
    [Abstract] [Full Text] [Related]

  • 19. Testicular leukemia inhibitory factor (LIF) and LIF receptor mediate phosphorylation of signal transducers and activators of transcription (STAT)-3 and STAT-1 and induce c-fos transcription and activator protein-1 activation in rat Sertoli but not germ cells.
    Jenab S, Morris PL.
    Endocrinology; 1998 Apr 25; 139(4):1883-90. PubMed ID: 9528974
    [Abstract] [Full Text] [Related]

  • 20. Alterations in Janus kinase (JAK)-signal transducers and activators of transcription (STAT) signaling in patients with end-stage dilated cardiomyopathy.
    Podewski EK, Hilfiker-Kleiner D, Hilfiker A, Morawietz H, Lichtenberg A, Wollert KC, Drexler H.
    Circulation; 2003 Feb 18; 107(6):798-802. PubMed ID: 12591746
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.